Filariasis research reagents and models resource for global study
Official title: Production and Distribution of Filarial Research Reagents
Funded at University of Georgia · NIH-11422926 · Data updated 2026-11-12
A NIH grant funds a resource center to provide parasites, models, and standardized tools to researchers studying lymphatic filariasis and related diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $1,023,862 |
| NIH project number | 1R24AI201120-01 |
| Project ID | NIH-11422926 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and laboratories studying filariasis and related neglected tropical diseases.
✕Less likely to help
Direct patient involvement is not part of this grant; benefit comes from enhanced research tools and models.
What this research studies
This project will keep supplying Brugia malayi, B. pahangi, and related materials to researchers worldwide, and will modernize how these resources are maintained. It will automate insectary processes and incorporate an artificial blood meal system to save time, reduce costs, and improve animal welfare. It will also develop scalable mouse and rat models to speed up drug screening and make studies more accessible, supporting efforts to eliminate lymphatic filariasis and monitor progress after elimination.
Why it matters
Potential benefit: Patients could benefit indirectly through faster development of vaccines and drugs for filariasis, supported by improved research resources.
How similar studies have gone: Previous FR3 resources have accelerated filariasis research; this grant aims to sustain and expand that impact with new models and QA panels.
Where this research is happening
-
University of Georgia
Athens, United States Active
Researchers
- Principal investigator: Campbell, Elyssa — University of Georgia
- Study coordinator: Campbell, Elyssa
Related research
Other NIH-funded projects on the same topics.
-
BRD4 and NIPBL work together to control facial bone development
A study in mice and cell models will explore how BRD4 and NIPBL work together to control how genes are turned on in facial development, which could clarify causes of craniofacial disorders.
-
Sulfated glycosaminoglycan hydrogels to protect brain volume after traumatic injury
A new implantable gel made from specially sulfated sugars may help prevent brain shrinkage and improve function after a serious brain injury.
-
Understanding how Kaposi’s sarcoma virus switches on late genes during infection
Scientists are studying how the virus causing Kaposi’s sarcoma turns on late genes when its DNA copies itself, which could reveal new ways to treat cancer in people with AIDS.
-
Understanding how cells control signals and adhesion with the secretory pathway
A funded NIH project looks at how the cell’s secretory system shapes signals, receptors, and attachment to the outside of the cell, which can influence many human diseases.
-
AI-powered math and machine learning for bioscience and drug discovery
A broad NIH grant supports using advanced math and AI to better predict viral variants and aid drug discovery, with the goal of helping patients by accelerating pandemic response.
-
AI-driven platform to predict vaccine-escape variants and design mutation-proof antibodies
An AI-powered approach aims to anticipate SARS-CoV-2 variants that may dodge vaccines and to create antibodies that stay effective.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.